The 96-week Stopping Atherosclerosis and Treating Unhealthy Bone with Rosuvastatin in HIV ( SATURN-HIV ) trial randomized 147 patients on stable antiretroviral therapy with low-density lipoprotein-cholesterol level lower than 130mg/dl and without overt heart failure to 10mg daily rosuvastatin or placebo .